Study outcome
The primary outcome was IA success and ablation
applications. Secondary outcomes included immediate success,
periprocedural complications, and VA recurrence. Clinical PVC frequency
more than 10% of baseline or any episode of VT documented by 24-hours
Holter was termed VA recurrence.12 An independent
events committee judged all adverse events and their relation to
ablation.